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The Mitral Stenosis is a common disease, which increased heart rate can be a sign of 
deterioration. Patient heart rate regulation, especially during exercise, is very 
important. The aim of this study was to evaluate the efficacy of Ivabradine in 
comparison with Atenolol and Metoprolol beta-blockers by examining Maximum 
exercise heart rate in patients with Mitral Valve Stenosis. 
Methods and Results 
In order to evaluate the efficacy of Ivabradine in comparison with beta-blockers, the 
systematic search was conducted using PICO keywords in the most important 
electronic databases, Cochrane Library, PubMed, Web of Science, CRD, Scopus, 
and Google Scholar. The articles were selected separately by reviewing the titles, 
abstract and full text of the articles, and extracting unrelated and repetitive articles 
by two individuals. Extracting the article information based on the measured 
outcome of Maximum exercise heart rate was done by two individuals 
independently.  In cases where there was disagreement, the decision was made by a 
third person. To evaluate the quality of the articles, the Cochrane tool and the 
Revman software version 5.3 were used. The I2 index was used to investigate the 
heterogeneity of the products. The publication bias between studies was evaluated 
using a Funnel Plot and Egger's Regression Test. The results of the fixed effects 
model were used to combine the results and the mean difference with 95% 
confidence interval for the consequences was calculated. This meta-analysis was 
performed using the Meta Package R software. Finally, four studies entered meta-
analysis. The total number of patients treated with Ivabradine and beta-blockers was 
128 and 132, respectively. Homogeneity between studies was not significant (I2 = 
36%; P-value = 0.20). The results of meta-analysis showed that the difference in 
mean Max Exercise HR of patients was 3.73, which was statistically significant 
(Mean Difference = 3.73; 95% CI: 1.52; 5.94; P-value = 0.001). 
Conclusions 
The administration of Ivabradine, in contrast to Atenolol and Metoprolol, greatly 
increases the ability of a person to test exercise, administration of this drug in 
patients with mitral valve stenosis can lead to a decrease in heart rate, which in turn 
causes reducing the risk of heart attacks in these patients. 
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